GLP-1 side effects are mostly digestive: nausea, diarrhea, vomiting, constipation, belly pain, indigestion, and reflux are the problems people taking semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) report most often. They are usually worst in the first weeks and after each dose increase, and for most people they ease with time on a stable dose. This page explains why GLP-1 side effects happen, how common each one is, what eating and drinking changes can help, and which symptoms point to something more serious. It draws on the current FDA prescribing information for Wegovy and Zepbound, published on DailyMed, and on the 2025 joint advisory on nutrition during GLP-1 therapy from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society.
This article is general education, not medical advice. Your prescribing clinician manages the medicine, the dose, and the schedule. Do not stop, skip, or change a dose without talking with them first.
Why GLP-1 side effects are mostly digestive
GLP-1 medications copy a hormone the gut releases after eating. Both prescribing labels state that the drugs delay gastric emptying, which means food stays in the stomach longer. That helps people feel full sooner and eat less, and it is also the main reason for nausea, bloating, and early fullness.
The joint advisory describes three overlapping causes of GLP-1 side effects in the gut:
- Slower stomach emptying. Food sitting longer in the stomach leads to bloating, fullness, and nausea.
- Effects on the brain. GLP-1 medications act on brain regions that control appetite and nausea.
- Changes in the bowel. Occasionally the drugs change how the intestine moves or what it secretes, which can contribute to diarrhea.
The advisory also notes that higher doses are more likely to cause these symptoms. The Zepbound label adds a detail about timing: the delay in stomach emptying is largest after the first dose and lessens over time.
How common GLP-1 side effects are
The figures below come from the adult weight-management trials summarized in each drug's current prescribing information. Each pair compares people taking the medicine with people taking a placebo, because some people on placebo also report these symptoms.
Semaglutide 2.4 mg weekly injection (Wegovy), compared with placebo:
- Nausea: 44% vs 16%
- Diarrhea: 30% vs 16%
- Vomiting: 24% vs 6%
- Constipation: 24% vs 11%
- Abdominal pain: 20% vs 10%
- Indigestion (dyspepsia): 9% vs 3%
- Belching: 7% vs less than 1%
- Reflux (GERD): 5% vs 3%
Tirzepatide 15 mg weekly injection (Zepbound), compared with placebo:
- Nausea: 28% vs 8%
- Diarrhea: 23% vs 8%
- Vomiting: 13% vs 2%
- Constipation: 11% vs 5%
- Abdominal pain: 10% vs 5%
- Indigestion: 10% vs 4%
- Belching: 5% vs 1%
- Reflux: 5% vs 2%
Overall, the Wegovy label reports digestive side effects in 73% of adults taking the injection and 47% taking placebo. It is tempting to read the two lists as a head-to-head comparison, but the joint advisory cautions against that. It notes that the placebo groups in the two sets of trials had different background rates, and that the increase over placebo is similar for many side effects with both drugs. These figures are a general picture, not a prediction for any one person.
When GLP-1 side effects are most likely
The Wegovy label states that digestive side effects were reported most often while the dose was being stepped up. The joint advisory agrees: side effects are more likely in the first weeks of treatment and with each dose increase, and they tend to become less frequent and less severe on a stable dose. In the trials, the advisory notes, people could stay at a dose for up to eight weeks to let symptoms settle before going higher. Pacing the increases is a decision for your prescribing clinician.
How often people stop because of them
Most people in the trials kept taking the medicine. In the Wegovy injection trials, 4.3% of adults stopped because of a digestive side effect, compared with 0.7% on placebo. In the Zepbound trials, 4.8% to 6.7% of people, depending on dose, stopped for any side effect, compared with 3.4% on placebo, and the label states that most of those who stopped did so in the first few months because of digestive symptoms. Outside of trials, the joint advisory reports that moderate or severe digestive side effects are one of the factors linked to stopping treatment.
Managing nausea and vomiting
Nausea is the most common GLP-1 side effect. The joint advisory notes that it often shows up in the morning or after long stretches without food, and that some people fall into a cycle: nausea makes them skip meals, and an empty stomach makes the nausea worse. The advisory's practical suggestions:
- Eat smaller, more frequent meals. The advisory suggests a small breakfast, then small meals every three to four hours.
- In the first few days of treatment, go easy on fatty and high-fiber foods.
- Avoid large meals. The advisory notes that vomiting is more likely after a big meal.
- Drink enough fluid through the day.
- Ginger or peppermint tea, or acupressure wristbands, may help some people.
- Keep alcohol to a minimum, since it can worsen nausea and reflux during GLP-1 therapy.
The advisory also notes that anti-nausea medicine can help while the body adjusts and around dose increases, and that some anti-nausea drugs can worsen constipation, which matters when constipation is already a problem. Which medicine, if any, is a question for your prescribing clinician.
Nausea that does not settle on a stable dose, or that keeps you from eating, deserves a closer look. Our page on chronic nausea and vomiting explains how gastroenterologists look for other causes.
Managing constipation
The joint advisory calls constipation common with weight loss and recommends managing it early rather than waiting. It also points out that constipation that goes on too long can lead to bouts of loose stool, which can be confusing. Its suggestions:
- Drink enough fluids.
- Increase fiber from food gradually. Prunes and other dried fruits are examples the advisory gives.
- Favor foods with more water and fewer calories, such as many fruits and vegetables, which leave the stomach faster.
- Know that high-fat and high-protein foods slow the stomach further and can make constipation worse, so they may need to be limited for a while.
If food changes are not enough, the advisory names other options: magnesium supplements such as magnesium citrate, fiber supplements, polyethylene glycol 3350, and stool softeners to avoid straining. Ask your prescribing clinician or pharmacist which fits you, especially if you have kidney disease or take other medicines.
Constipation can also become serious. Both labels list reports after approval of ileus (a bowel that stops moving), intestinal blockage, and severe constipation with fecal impaction. Our page on chronic constipation covers when constipation needs medical evaluation.
Managing diarrhea
For diarrhea, the joint advisory suggests avoiding large or high-fat meals. If diarrhea is significant, fiber capsules or powders can add bulk to the stool, and anti-diarrhea medicines can give short-term relief. Diarrhea also drains fluid, which matters for the kidneys, as explained below. Diarrhea that continues for weeks, wakes you at night, or comes with blood is not a typical pattern and should be checked; our page on chronic diarrhea explains the usual workup.
Reflux, belching, and bloating
Reflux, indigestion, belching, bloating, and gas all appear on both labels' lists of side effects reported more often than with placebo. Slower stomach emptying is the likely link: a fuller stomach for longer means more pressure upward. The same eating habits that help nausea, smaller meals and less fat, may help here too, and the joint advisory names alcohol as something that can worsen reflux during treatment.
If you had GERD before starting, or reflux symptoms are new and persistent, tell your prescribing clinician. Our pages on excessive belching and chronic bloating and gas cover other causes worth ruling out.
Serious GLP-1 side effects to know
Less common GLP-1 side effects can be serious. Both prescribing labels list them in their warnings sections, and the joint advisory calls them rare. Knowing the symptoms is the practical point.
Severe digestive reactions
Both labels carry a warning for severe digestive side effects. In the trials, they were reported in 4.1% of adults taking the Wegovy injection and 0.9% taking placebo, and in 1.7% to 3.1% of people taking Zepbound, depending on dose, compared with 1% taking placebo. Both labels state that the drug is not recommended for people with severe gastroparesis.
Dehydration and kidney injury
Both labels report kidney injury after approval, in some cases needing dialysis, and state that most of these cases happened in people who had become dehydrated from nausea, vomiting, or diarrhea. The Zepbound Medication Guide advises drinking fluids to reduce the chance of dehydration and calling your healthcare provider right away if nausea, vomiting, or diarrhea does not go away. The joint advisory adds that people with kidney disease, or at risk for it, should get specific advice on preventing dehydration.
Gallbladder problems
Both labels associate these drugs with more gallstones and gallbladder inflammation. In the Zepbound trials, gallbladder inflammation was reported in 0.7% of people taking the drug and 0.2% taking placebo, and the label links these events to weight loss. The Zepbound Medication Guide lists the symptoms to report right away: pain in the upper stomach, fever, yellowing of the skin or eyes, and clay-colored stools. Our page on gallstones explains how they are evaluated.
Pancreatitis
Acute pancreatitis, including rare severe and fatal cases, has been observed with GLP-1 medications. Both labels describe the warning sign as persistent or severe abdominal pain, sometimes spreading to the back, with or without nausea or vomiting, and both direct that the drug be stopped if pancreatitis is suspected. Pain like that needs prompt medical care, not a wait-and-see approach.
Symptoms that should not wait
Get prompt medical care if you have:
- Severe or persistent belly pain, especially if it spreads to the back
- Vomiting that keeps you from holding down fluids
- Signs of dehydration, such as very little urine, dizziness, or a racing heart
- A swollen, painful belly, or no stool or gas for days
- Upper belly pain with fever, yellow skin or eyes, or pale stools
When the cause may not be the medication
New digestive symptoms in someone taking a GLP-1 medication are often from the drug, but not always. Some symptoms are not among the side effects listed in the prescribing information and need their own evaluation, whatever medicines you take:
- Black or tarry stools, vomiting blood, or blood in the stool
- Trouble swallowing, or food that feels stuck
- Symptoms that start or worsen months into a stable dose rather than during an increase
- Anemia found on blood tests
Weight loss is the goal of many GLP-1 prescriptions, so it can hide another problem. If you are losing weight faster than your clinician expected, or cannot eat enough because of symptoms, say so. The joint advisory also stresses that eating much less can lead to low intake of protein, vitamins, and minerals, and recommends nutrition counseling during treatment.
GLP-1 side effects and other pills
Because GLP-1 medications slow the stomach, they can change how other medicines taken by mouth are absorbed. Both labels advise extra monitoring for oral drugs where small changes in absorption matter, and the Zepbound label gives warfarin as an example. The Zepbound label goes further for birth control pills: it advises switching to a non-oral method, or adding a barrier method, for four weeks after starting and for four weeks after each dose increase. Review your full medicine list with your prescribing clinician and pharmacist.
GLP-1 medications before an endoscopy or colonoscopy
Slower stomach emptying also matters for sedation. Both labels report rare cases of food being inhaled into the lungs during deep sedation or anesthesia in people taking these drugs, despite fasting as instructed, and both tell patients to inform their care team before any planned procedure. Current guidance on whether to hold the medicine, and how to adjust the diet before a procedure, is covered in our guide to GLP-1 medications and endoscopy.
What happens if you stop
Stopping usually ends the side effects, but it has its own trade-off. The joint advisory reports that weight regain is common after stopping, with up to two-thirds of lost weight regained within a year, even with standard nutrition counseling. It also notes that, in the authors' experience, some people do well staying at the lowest dose that works instead of stepping up. If GLP-1 side effects are making treatment hard, talk with your prescribing clinician about pacing, dose, or a different medicine before stopping on your own.
Questions to bring to your appointment
- Are my symptoms typical GLP-1 side effects, or could something else be going on?
- Should I stay at my current dose longer before increasing?
- Which anti-nausea or constipation remedy is safe with my other medicines?
- How much fluid should I aim for, and what signs of dehydration should prompt a call?
- Do any of my other pills need monitoring or a change while I take this medicine?
- Would working with a registered dietitian help me eat enough protein and fiber?
Digestive care during GLP-1 treatment in Northern Virginia
Gastroenterology Center of Northern Virginia cares for adults across Arlington, Annandale, and the surrounding communities. Our physicians evaluate digestive symptoms in people taking GLP-1 medications, including nausea, vomiting, constipation, diarrhea, reflux, and abdominal pain, help sort out whether the medicine or another condition is responsible, and coordinate with the clinician who prescribes the medicine. If this is your first visit, our guide to your first gastroenterologist visit explains what to bring. For GLP-1 side effects, that includes the name and dose of your medicine, when you started and when the dose last changed, a list of your other medicines, and a short log of your symptoms.
We see patients at our Arlington office at 1715 N George Mason Drive, adjacent to VHC Health, and our Annandale office at 3299 Woodburn Road in the Woodburn Medical complex. To schedule a visit, call Arlington at (703) 522-7476 or Annandale at (703) 560-6106, or learn more at gcofnova.com.
Frequently asked questions about GLP-1 side effects
What are the most common GLP-1 side effects?
Digestive symptoms. In the adult weight-management trials in the current prescribing information, nausea, diarrhea, vomiting, constipation, and abdominal pain were the most common, followed by indigestion, belching, bloating, and reflux. For semaglutide 2.4 mg, nausea was reported by 44% of people, compared with 16% on placebo.
How long do GLP-1 side effects last?
They are usually worst in the first weeks and after each dose increase, and tend to ease on a stable dose, according to the 2025 joint advisory on nutrition during GLP-1 therapy. Symptoms that persist at a stable dose, or that start months into treatment, should be discussed with your clinician.
What should I eat to reduce nausea on a GLP-1 medication?
The joint advisory suggests small, frequent meals, such as a small breakfast and then small meals every three to four hours, avoiding large meals, going easy on fatty and high-fiber foods in the first days, drinking enough fluid, and keeping alcohol to a minimum. Ginger or peppermint tea may help some people.
Can a GLP-1 medication cause constipation?
Yes. Constipation was reported by 24% of adults taking semaglutide 2.4 mg and 11% of people taking tirzepatide 15 mg in the weight-management trials. Fluids, gradually adding fiber from food, and, if needed, options your clinician approves can help. Severe constipation with impaction and bowel blockage have been reported after approval, so a swollen, painful belly or no stool or gas needs prompt care.
Which GLP-1 side effects are serious?
The prescribing labels warn about severe digestive reactions, kidney injury from dehydration, gallbladder disease, and pancreatitis. Severe belly pain that may spread to the back, vomiting that keeps you from holding down fluids, upper belly pain with fever or yellow skin, and a swollen belly with no stool or gas all need prompt medical care.
Should I stop my GLP-1 medication if I have side effects?
Not on your own, unless you have warning signs such as suspected pancreatitis, which need urgent care. For everyday symptoms, talk with your prescribing clinician about pacing dose increases or staying at a lower dose. The joint advisory notes that weight regain is common after stopping, with up to two-thirds of lost weight regained within a year.
This article is for general education and is not medical advice. Figures and recommendations described here come from the current FDA prescribing information and Medication Guides for Wegovy (semaglutide, revised June 2026) and Zepbound (tirzepatide, revised August 2026) published on DailyMed, and from the joint advisory "Nutritional priorities to support GLP-1 therapy for obesity" from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society (2025). Your own care depends on your symptoms, your history, and your physicians' judgment. Talk with your prescribing clinician about your medicine, and with a qualified gastroenterologist about your digestive symptoms, diagnosis, and treatment options.